BIO-key Receives Notice of Non-Compliance from Nasdaq Related to Delay of its Form 10-Q Filing
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
BIO-key (OTC Markets: BKYI) received a Nasdaq notice of non-compliance with Listing Rule 5250(c)(1) because it did not timely file its Form 10-Q for the quarter ended March 31, 2026.
A Nasdaq Hearing Panel will consider this issue when deciding BIO-key’s continued listing on the Nasdaq Capital Market.
Positive
- None.
Negative
- Non-compliance with Nasdaq Listing Rule 5250(c)(1) for late Form 10-Q filing
- Nasdaq Hearing Panel to weigh non-compliance in continued listing determination
Details
News Market Reaction – BKYI
On Jun 11, the first trading day after this news, BKYI closed 2.81% below the previous close.
Data tracked by StockTitan Argus for the Jun 11 session.
Historical Context
-
Outlined expected 1H 2026 revenue growth and anticipated first-half profitability.
-
Announced BlueAlly partnership and PortalGuard deployment at AOD Federal Credit Union.
-
Detailed biometric authentication deployment reducing credential risks and IT workloads.
-
Reported higher Q1 revenue, narrowed loss, and guided to stronger Q2 and 1H 2026.
-
Disclosed Nasdaq trading suspension and OTC move while reiterating growth and profit targets.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
form 10-q regulatory
nasdaq listing rule 5250(c)(1) regulatory
securities and exchange commission regulatory
nasdaq capital market regulatory
identity and access management technical
biometric authentication technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
HOLMDEL, N.J., June 10, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (OTC Markets: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, announced today that it has received a notification letter from The Nasdaq Stock Market, LLC informing the Company that it was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission, due to the Company’s failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2026. In the notice, Nasdaq further informed the Company that the Nasdaq Hearing Panel will consider the forgoing in rendering a determination regarding the Company’s continued listing on the Nasdaq Capital Market.
About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its cloud hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.
| Engage with BIO-key: | |
| Facebook – Corporate: | https://www.facebook.com/BIOkeyInternational/ |
| LinkedIn – Corporate: | https://www.linkedin.com/company/bio-key-international |
| X – Corporate: | @BIOkeyIntl |
| X – Investors: | @BIO_keyIR |
| StockTwits: | BIO_keyIR |
Investor Contacts:
William Jones, David Collins
Catalyst IR
BKYI@catalyst-ir.com
212-924-9800
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.